Crossmark

Treatment Beyond Progression in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab in CheckMate 025

Crossref DOI link: https://doi.org/10.1016/j.eururo.2017.03.037

Published Print: 2017-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Escudier, Bernard

Motzer, Robert J.

Sharma, Padmanee

Wagstaff, John

Plimack, Elizabeth R.

Hammers, Hans J.

Donskov, Frede

Gurney, Howard

Sosman, Jeffrey A.

Zalewski, Pawel G.

Harmenberg, Ulrika

McDermott, David F.

Choueiri, Toni K.

Richardet, Martin

Tomita, Yoshihiko

Ravaud, Alain

Doan, Justin

Zhao, Huanyu

Hardy, Helene

George, Saby
License Information

Text and Data Mining valid from 2017-09-01
More Information

This article is maintained by: Elsevier

Article Title: Treatment Beyond Progression in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab in CheckMate 025

Journal Title: European Urology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eururo.2017.03.037

Content Type: article

Copyright: © 2017 European Association of Urology. Published by Elsevier B.V. All rights reserved.